GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (FRA:BUWA) » Definitions » Cyclically Adjusted FCF per Share

Bio-Rad Laboratories (FRA:BUWA) Cyclically Adjusted FCF per Share : €7.70 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Bio-Rad Laboratories Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bio-Rad Laboratories's adjusted free cash flow per share for the three months ended in Mar. 2024 was €0.955. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €7.70 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Bio-Rad Laboratories's average Cyclically Adjusted FCF Growth Rate was 5.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 12.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 14.50% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Bio-Rad Laboratories was 93.80% per year. The lowest was -22.40% per year. And the median was 11.55% per year.

As of today (2024-05-28), Bio-Rad Laboratories's current stock price is €263.50. Bio-Rad Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €7.70. Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF of today is 34.22.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bio-Rad Laboratories was 129.56. The lowest was 22.14. And the median was 50.79.


Bio-Rad Laboratories Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Bio-Rad Laboratories's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Cyclically Adjusted FCF per Share Chart

Bio-Rad Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.07 4.56 6.36 6.98 7.32

Bio-Rad Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.02 7.36 7.70 7.32 7.70

Competitive Comparison of Bio-Rad Laboratories's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF falls into.



Bio-Rad Laboratories Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bio-Rad Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.955/131.7762*131.7762
=0.955

Current CPI (Mar. 2024) = 131.7762.

Bio-Rad Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1.086 100.560 1.423
201409 1.683 100.428 2.208
201412 0.003 99.070 0.004
201503 0.033 99.621 0.044
201506 0.192 100.684 0.251
201509 1.740 100.392 2.284
201512 0.248 99.792 0.327
201603 -0.997 100.470 -1.308
201606 1.371 101.688 1.777
201609 0.365 101.861 0.472
201612 1.575 101.863 2.038
201703 -2.986 102.862 -3.825
201706 0.978 103.349 1.247
201709 0.231 104.136 0.292
201712 1.213 104.011 1.537
201803 0.354 105.290 0.443
201806 1.449 106.317 1.796
201809 1.138 106.507 1.408
201812 1.488 105.998 1.850
201903 0.568 107.251 0.698
201906 3.909 108.070 4.766
201909 2.090 108.329 2.542
201912 4.107 108.420 4.992
202003 1.232 108.902 1.491
202006 2.186 108.767 2.648
202009 3.260 109.815 3.912
202012 6.678 109.897 8.008
202103 2.618 111.754 3.087
202106 3.613 114.631 4.153
202109 5.505 115.734 6.268
202112 3.354 117.630 3.757
202203 0.528 121.301 0.574
202206 1.141 125.017 1.203
202209 -0.562 125.227 -0.591
202212 1.383 125.222 1.455
202303 1.959 127.348 2.027
202306 1.994 128.729 2.041
202309 1.720 129.860 1.745
202312 1.236 129.419 1.259
202403 0.955 131.776 0.955

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Bio-Rad Laboratories  (FRA:BUWA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=263.50/7.7
=34.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bio-Rad Laboratories was 129.56. The lowest was 22.14. And the median was 50.79.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bio-Rad Laboratories Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories (FRA:BUWA) Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Bio-Rad Laboratories (FRA:BUWA) Headlines

No Headlines